Arwen Pieterse, PhD, and colleagues urge all physicians to allocate more meaningful time to collaborate in shared decision making with patients, without compromising access or productivity…
Autologous Serum Tears Receives High Patient Satisfaction Scores for Dry Eye Disease
Although not a first-line treatment, autologous serum tears are often used as a treatment option for dry eyes related to both ophthalmic and rheumatic conditions. Recent research into its efficacy also evaluated the treatment’s patient satisfaction, finding autologous serum tears reduced symptoms of dry eye disease and received high patient satisfaction scores…
Long-Term Physical Activity Lowers the Risk of RA among Women
A new study adds to the evidence that metabolic factors play an important role in the pathogenesis of rheumatoid arthritis (RA). In this large, prospective cohort study, Liu et al. found that increased physical activity among women was associated with a reduced risk of RA…
Osteoporosis Drugs Don’t Reduce Overall Mortality
NEW YORK (Reuters Health)—Anti-fracture medications do not reduce overall mortality in older patients with osteoporosis, according to an updated systematic review and meta-analysis. “This meta-analysis suggests drug treatments, including treatment with bisphosphonates, for osteoporosis should be recommended only for the prevention of fracture and not for any additional reduction in mortality,” researchers write in JAMA…
Shingles Vaccine Not the Only Immunization Linked with Gout Flare
NEW YORK (Reuters Health)—The recombinant shingles vaccine (RZV) is associated with an increased risk of gout flare, and a new study suggests other vaccines may trigger flares as well, researchers say. “Our findings are novel because for the first time, we have identified a trigger for gout flares that presumably acts through [an inflammatory] pathway,…
Improved Pregnancy Outcomes for Women with SLE
Recent research indicates that previous concerns about mortality associated with pregnancy in women with SLE may no longer be applicable. In the study, researchers found a significant decline in the in-hospital maternal mortality rate of women with SLE and a decrease in their length of non-delivery related hospitalization over the past two decades…
FDA Approves AbbVie’s New Rheumatoid Arthritis Drug
(Reuters)—The U.S. Food and Drug Administration (FDA) on Friday approved AbbVie Inc.’s new treatment for rheumatoid arthritis (RA), a win for the drugmaker seeking to widen its portfolio as its blockbuster flagship therapy Humira (adalimumab) faces competition. The drug, Rinvoq (upadacitinib), is a JAK inhibitor. It is set to compete with Pfizer Inc.’s Xeljanz (tofacitinib)…
ACR Prepares to Submit Rheumatoid Arthritis Alternative Payment Model
The ACR will soon submit the updated Rheumatoid Arthritis Alternative Payment Model to the Physician-Focused Payment Model Technical Advisory Committee for review and feedback.
Advocates for Arthritis Will Target Step Therapy, Workforce Shortage
The 2019 event, to be held Sept. 9-10 in Washington, D.C., will bring together rheumatology professionals and patients to advocate on behalf of the rheumatology community.
Proposed 2020 E/M Codes Include Reimbursement Changes
Increased reimbursement would reflect value of cognitive care and other time-intensive services provided by rheumatologists.
- « Previous Page
- 1
- …
- 109
- 110
- 111
- 112
- 113
- …
- 317
- Next Page »